Pfizer, BioNTech start clinical trial of Omicron-specific Covid-19 vaccine
Published
Published
Pfizer/BioNTech said they have started clinical trials for a version of their vaccine targeting the highly-transmissible variant.
They are also testing a fourth dose of the current vaccine against a fourth dose of the Omicron-based vaccine in people who..